anticoagulant

pass the torch deal sell buy acquisition
Biotech

Novartis inks $925M Anthos takeover to rejoin clot-busting race

Six years after spinning the asset out, Novartis has struck a deal to buy Anthos to add the clot-busting prospect to its late-phase pipeline.
Nick Paul Taylor Feb 11, 2025 5:21am
Graphic of a drop of blood made up of small data points and nodes

Regeneron anticoagulant bests enoxaparin, matches Eliquis

Dec 19, 2024 8:50am
visual of red blood cells

Blackstone's $250M bet beats Xarelto in phase 2 bleeding trial

Sep 18, 2023 6:00am
neural regeneration

BMS, J&J's secondary stroke med doesn't stick the landing

Aug 28, 2022 3:36am
Merck Co

Racing Bayer, Merck gets FDA fast-track tag for anticoagulant

Aug 23, 2022 8:40am
blood test tube

Bayer-Ionis' anti-thrombotic med doesn't increase bleeding

Jul 28, 2022 10:51am